letermovir (prevymis) Report issue

Small molecule Orphan Drug FDA Approved FDA First in Class Fast Track FDA Priority Review FDA

Back

Chemistry

Mol. Mass

572.56

ALogP

5.71

Rule of 5

No

Rule of 3

No
Details
  • SMILES: COc1cccc(c1)N2CCN(CC2)C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c5cc(ccc5OC)C(F)(F)F
  • InChIKey: FWYSMLBETOMXAG-QHCPKHFHSA-N
    InChI=1S/C29H28F4N4O4/c1-40-20-6-3-5-19(16-20)35-11-13-36(14-12-35)28-34-27-21(7-4-8-22(27)30)23(17-26(38)39)37(28)24-15-18(29(31,32)33)9-10-25(24)41-2/h3-10,15-16,23H,11-14,17H2,1-2H3,(H,38,39)/t23-/m0/s1
  • Chirality: Single Stereoisomer
  • Inorganic: No
  • Polymer: No

Sources

CHEMBL1241951   ChEMBL
letermovir *

1H09Y5WO1F   NCATS
letermovir *

Letermovir   Wikipedia

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue